Claria Medical develops minimally invasive surgical tools aimed at improving hysterectomy and myomectomy procedures, addressing the need for safer and more effective surgical options in women's healthcare. The company has received a “Safer Technologies Designation” from the FDA and secured grants from the National Science Foundation and National Institutes of Health to advance its product development.
Funding
$13M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
OFounders
Product
Problem
Hysterectomy and myomectomy procedures often involve invasive surgical techniques, leading to longer recovery times, increased risk of complications, and potential impact on a woman's reproductive health. Current surgical options may not always provide the safest or most effective solutions for addressing various gynecological conditions.
Solution
Claria Medical is developing minimally invasive surgical tools designed to improve the safety and efficacy of hysterectomy and myomectomy procedures. These tools aim to reduce the invasiveness of traditional surgical approaches, potentially leading to faster recovery times and fewer complications for patients. By focusing on minimally invasive techniques, Claria Medical seeks to provide surgeons with advanced instruments that enhance precision and control during gynecological surgeries. The company's technology is intended to offer women a less traumatic surgical experience with improved outcomes.
Target Audience
The primary target audience includes surgeons specializing in gynecology and women undergoing hysterectomy or myomectomy procedures.
Features
- Minimally invasive surgical instruments for hysterectomy and myomectomy
- Focus on enhanced precision and control during surgical procedures
- Designed to reduce recovery times and minimize complications